Loading…
Alterations in coagulatory and fibrinolytic systems following an ultra-marathon
Purpose The aim of this study was to examine coagulatory and fibrinolytic responses to the Western States Endurance Run (WSER, June 23 to 24, 2012). The WSER is a 161-km (100 mile) trail foot race through the Sierra Nevada Mountains that involves 6,030 m of climb and 7,001 m of descent. Methods We e...
Saved in:
Published in: | European journal of applied physiology 2013-11, Vol.113 (11), p.2705-2712 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c405t-8f736164a0db8574c7598786e7a8e5d0802df4ecfa2af813d7da405d30d2a37c3 |
---|---|
cites | cdi_FETCH-LOGICAL-c405t-8f736164a0db8574c7598786e7a8e5d0802df4ecfa2af813d7da405d30d2a37c3 |
container_end_page | 2712 |
container_issue | 11 |
container_start_page | 2705 |
container_title | European journal of applied physiology |
container_volume | 113 |
creator | Kupchak, Brian R. Volk, Brittanie M. Kunces, Laura J. Kraemer, William J. Hoffman, Martin D. Phinney, Stephen D. Volek, Jeff S. |
description | Purpose
The aim of this study was to examine coagulatory and fibrinolytic responses to the Western States Endurance Run (WSER, June 23 to 24, 2012). The WSER is a 161-km (100 mile) trail foot race through the Sierra Nevada Mountains that involves 6,030 m of climb and 7,001 m of descent.
Methods
We examined 12 men and 4 women [mean (95 % CI), age 44.6 years (38.7–50.6)] who completed the race (24.64 h; range 16.89–29.46). Blood samples were collected the morning before the race, immediately post-race, and 1 (D1) and 2 (D2) days post-race (corresponding to 51–54 h and 75–78 h from the start of the race, respectively). Hypercoagulable state was characterized by prothrombin fragment 1+2 (PTF 1+2) and thrombin–antithrombin complex (TAT). Fibrinolytic state was assessed by plasminogen activator inhibitor antigen (PAI-1 Ag), tissue plasminogen activator antigen (tPA Ag), and
d
-Dimer. Muscle damage was assessed by serum creatine kinase (CK) and myoglobin concentrations.
Results
Significant (
P
≤ 0.05) increases were observed immediately post-race for thrombin generation markers, PTF 1+2 (3.9-fold) and TAT (2.4-fold); markers of fibrinolysis, tPA Ag (4.0-fold), PAI-1 Ag (4.5-fold), and
d
-Dimer (2.2-fold); and muscle damage markers, CK (154-fold) and myoglobin (114-fold). Most markers continued to be elevated at D1, as seen by PTF 1+2, TAT (1.5- and 1.3-fold increase at D1), and
d
-Dimer (2.5- and 2.1-fold increase at D1 and D2, respectively). Additionally, PTF 1+2:tPA and TAT:tPA ratios, which assessed balance between coagulation and fibrinolysis, were slightly, but significantly increased at D1 (69 and 36 %) and D2 (19 and 31 %). CK and myoglobin also remained elevated at D1 (54- and 7-fold) and D2 (25- and 2-fold) time points.
Conclusion
The WSER produced extensive muscle damage and activated the coagulation and fibrinolytic systems. Since we observed a slight imbalance response between the two systems, a limited potential for thrombotic episodes is apparent in these highly trained athletes. |
doi_str_mv | 10.1007/s00421-013-2709-5 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1622605978</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1622605978</sourcerecordid><originalsourceid>FETCH-LOGICAL-c405t-8f736164a0db8574c7598786e7a8e5d0802df4ecfa2af813d7da405d30d2a37c3</originalsourceid><addsrcrecordid>eNqFkctKAzEUhoMoXqoP4EYG3LgZPblMklmW4g0K3eg6pJNMHUmTmswg8_amVEUEcZUD-f7_kHwInWO4xgDiJgEwgkvAtCQC6rLaQ8eY0brklIj97xnXR-gkpVcAkATLQ3REaC2YZPIYLaaut1H3XfCp6HzRBL0anO5DHAvtTdF2y9j54Ma-a4o0pt6uU9EG58J751cZKQbXR12udS55Cf4UHbTaJXv2eU7Q893t0-yhnC_uH2fTedkwqPpStoJyzJkGs5SVYI2oaikkt0JLWxmQQEzLbNNqoluJqRFG56ChYIimoqETdLXr3cTwNtjUq3WXGuuc9jYMSWFOCIeqFvJ_lDHKCMekyujlL_Q1DNHnhyhcccprUcOWwjuqiSGlaFu1iV3-gFFhUFsxaidGZTFqK0ZtMxefzcNybc134stEBsgOSPnKr2z8sfrP1g-MdJgO</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1563697905</pqid></control><display><type>article</type><title>Alterations in coagulatory and fibrinolytic systems following an ultra-marathon</title><source>Springer Nature</source><creator>Kupchak, Brian R. ; Volk, Brittanie M. ; Kunces, Laura J. ; Kraemer, William J. ; Hoffman, Martin D. ; Phinney, Stephen D. ; Volek, Jeff S.</creator><creatorcontrib>Kupchak, Brian R. ; Volk, Brittanie M. ; Kunces, Laura J. ; Kraemer, William J. ; Hoffman, Martin D. ; Phinney, Stephen D. ; Volek, Jeff S.</creatorcontrib><description>Purpose
The aim of this study was to examine coagulatory and fibrinolytic responses to the Western States Endurance Run (WSER, June 23 to 24, 2012). The WSER is a 161-km (100 mile) trail foot race through the Sierra Nevada Mountains that involves 6,030 m of climb and 7,001 m of descent.
Methods
We examined 12 men and 4 women [mean (95 % CI), age 44.6 years (38.7–50.6)] who completed the race (24.64 h; range 16.89–29.46). Blood samples were collected the morning before the race, immediately post-race, and 1 (D1) and 2 (D2) days post-race (corresponding to 51–54 h and 75–78 h from the start of the race, respectively). Hypercoagulable state was characterized by prothrombin fragment 1+2 (PTF 1+2) and thrombin–antithrombin complex (TAT). Fibrinolytic state was assessed by plasminogen activator inhibitor antigen (PAI-1 Ag), tissue plasminogen activator antigen (tPA Ag), and
d
-Dimer. Muscle damage was assessed by serum creatine kinase (CK) and myoglobin concentrations.
Results
Significant (
P
≤ 0.05) increases were observed immediately post-race for thrombin generation markers, PTF 1+2 (3.9-fold) and TAT (2.4-fold); markers of fibrinolysis, tPA Ag (4.0-fold), PAI-1 Ag (4.5-fold), and
d
-Dimer (2.2-fold); and muscle damage markers, CK (154-fold) and myoglobin (114-fold). Most markers continued to be elevated at D1, as seen by PTF 1+2, TAT (1.5- and 1.3-fold increase at D1), and
d
-Dimer (2.5- and 2.1-fold increase at D1 and D2, respectively). Additionally, PTF 1+2:tPA and TAT:tPA ratios, which assessed balance between coagulation and fibrinolysis, were slightly, but significantly increased at D1 (69 and 36 %) and D2 (19 and 31 %). CK and myoglobin also remained elevated at D1 (54- and 7-fold) and D2 (25- and 2-fold) time points.
Conclusion
The WSER produced extensive muscle damage and activated the coagulation and fibrinolytic systems. Since we observed a slight imbalance response between the two systems, a limited potential for thrombotic episodes is apparent in these highly trained athletes.</description><identifier>ISSN: 1439-6319</identifier><identifier>EISSN: 1439-6327</identifier><identifier>DOI: 10.1007/s00421-013-2709-5</identifier><identifier>PMID: 23974848</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Adult ; Altitude ; Antigens ; Biomedical and Life Sciences ; Biomedicine ; Creatine Kinase - blood ; Female ; Fibrinolysis ; Human Physiology ; Humans ; Male ; Marathons ; Middle Aged ; Myoglobin - blood ; Occupational Medicine/Industrial Medicine ; Original Article ; Physical Endurance - physiology ; Plasminogen Inactivators - blood ; Prothrombin - analysis ; Running - physiology ; Sports Medicine ; Thrombin - analysis ; Trails ; Ultramarathon ; Women</subject><ispartof>European journal of applied physiology, 2013-11, Vol.113 (11), p.2705-2712</ispartof><rights>Springer-Verlag Berlin Heidelberg 2013</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c405t-8f736164a0db8574c7598786e7a8e5d0802df4ecfa2af813d7da405d30d2a37c3</citedby><cites>FETCH-LOGICAL-c405t-8f736164a0db8574c7598786e7a8e5d0802df4ecfa2af813d7da405d30d2a37c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23974848$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kupchak, Brian R.</creatorcontrib><creatorcontrib>Volk, Brittanie M.</creatorcontrib><creatorcontrib>Kunces, Laura J.</creatorcontrib><creatorcontrib>Kraemer, William J.</creatorcontrib><creatorcontrib>Hoffman, Martin D.</creatorcontrib><creatorcontrib>Phinney, Stephen D.</creatorcontrib><creatorcontrib>Volek, Jeff S.</creatorcontrib><title>Alterations in coagulatory and fibrinolytic systems following an ultra-marathon</title><title>European journal of applied physiology</title><addtitle>Eur J Appl Physiol</addtitle><addtitle>Eur J Appl Physiol</addtitle><description>Purpose
The aim of this study was to examine coagulatory and fibrinolytic responses to the Western States Endurance Run (WSER, June 23 to 24, 2012). The WSER is a 161-km (100 mile) trail foot race through the Sierra Nevada Mountains that involves 6,030 m of climb and 7,001 m of descent.
Methods
We examined 12 men and 4 women [mean (95 % CI), age 44.6 years (38.7–50.6)] who completed the race (24.64 h; range 16.89–29.46). Blood samples were collected the morning before the race, immediately post-race, and 1 (D1) and 2 (D2) days post-race (corresponding to 51–54 h and 75–78 h from the start of the race, respectively). Hypercoagulable state was characterized by prothrombin fragment 1+2 (PTF 1+2) and thrombin–antithrombin complex (TAT). Fibrinolytic state was assessed by plasminogen activator inhibitor antigen (PAI-1 Ag), tissue plasminogen activator antigen (tPA Ag), and
d
-Dimer. Muscle damage was assessed by serum creatine kinase (CK) and myoglobin concentrations.
Results
Significant (
P
≤ 0.05) increases were observed immediately post-race for thrombin generation markers, PTF 1+2 (3.9-fold) and TAT (2.4-fold); markers of fibrinolysis, tPA Ag (4.0-fold), PAI-1 Ag (4.5-fold), and
d
-Dimer (2.2-fold); and muscle damage markers, CK (154-fold) and myoglobin (114-fold). Most markers continued to be elevated at D1, as seen by PTF 1+2, TAT (1.5- and 1.3-fold increase at D1), and
d
-Dimer (2.5- and 2.1-fold increase at D1 and D2, respectively). Additionally, PTF 1+2:tPA and TAT:tPA ratios, which assessed balance between coagulation and fibrinolysis, were slightly, but significantly increased at D1 (69 and 36 %) and D2 (19 and 31 %). CK and myoglobin also remained elevated at D1 (54- and 7-fold) and D2 (25- and 2-fold) time points.
Conclusion
The WSER produced extensive muscle damage and activated the coagulation and fibrinolytic systems. Since we observed a slight imbalance response between the two systems, a limited potential for thrombotic episodes is apparent in these highly trained athletes.</description><subject>Adult</subject><subject>Altitude</subject><subject>Antigens</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Creatine Kinase - blood</subject><subject>Female</subject><subject>Fibrinolysis</subject><subject>Human Physiology</subject><subject>Humans</subject><subject>Male</subject><subject>Marathons</subject><subject>Middle Aged</subject><subject>Myoglobin - blood</subject><subject>Occupational Medicine/Industrial Medicine</subject><subject>Original Article</subject><subject>Physical Endurance - physiology</subject><subject>Plasminogen Inactivators - blood</subject><subject>Prothrombin - analysis</subject><subject>Running - physiology</subject><subject>Sports Medicine</subject><subject>Thrombin - analysis</subject><subject>Trails</subject><subject>Ultramarathon</subject><subject>Women</subject><issn>1439-6319</issn><issn>1439-6327</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNqFkctKAzEUhoMoXqoP4EYG3LgZPblMklmW4g0K3eg6pJNMHUmTmswg8_amVEUEcZUD-f7_kHwInWO4xgDiJgEwgkvAtCQC6rLaQ8eY0brklIj97xnXR-gkpVcAkATLQ3REaC2YZPIYLaaut1H3XfCp6HzRBL0anO5DHAvtTdF2y9j54Ma-a4o0pt6uU9EG58J751cZKQbXR12udS55Cf4UHbTaJXv2eU7Q893t0-yhnC_uH2fTedkwqPpStoJyzJkGs5SVYI2oaikkt0JLWxmQQEzLbNNqoluJqRFG56ChYIimoqETdLXr3cTwNtjUq3WXGuuc9jYMSWFOCIeqFvJ_lDHKCMekyujlL_Q1DNHnhyhcccprUcOWwjuqiSGlaFu1iV3-gFFhUFsxaidGZTFqK0ZtMxefzcNybc134stEBsgOSPnKr2z8sfrP1g-MdJgO</recordid><startdate>20131101</startdate><enddate>20131101</enddate><creator>Kupchak, Brian R.</creator><creator>Volk, Brittanie M.</creator><creator>Kunces, Laura J.</creator><creator>Kraemer, William J.</creator><creator>Hoffman, Martin D.</creator><creator>Phinney, Stephen D.</creator><creator>Volek, Jeff S.</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>7TS</scope></search><sort><creationdate>20131101</creationdate><title>Alterations in coagulatory and fibrinolytic systems following an ultra-marathon</title><author>Kupchak, Brian R. ; Volk, Brittanie M. ; Kunces, Laura J. ; Kraemer, William J. ; Hoffman, Martin D. ; Phinney, Stephen D. ; Volek, Jeff S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c405t-8f736164a0db8574c7598786e7a8e5d0802df4ecfa2af813d7da405d30d2a37c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adult</topic><topic>Altitude</topic><topic>Antigens</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Creatine Kinase - blood</topic><topic>Female</topic><topic>Fibrinolysis</topic><topic>Human Physiology</topic><topic>Humans</topic><topic>Male</topic><topic>Marathons</topic><topic>Middle Aged</topic><topic>Myoglobin - blood</topic><topic>Occupational Medicine/Industrial Medicine</topic><topic>Original Article</topic><topic>Physical Endurance - physiology</topic><topic>Plasminogen Inactivators - blood</topic><topic>Prothrombin - analysis</topic><topic>Running - physiology</topic><topic>Sports Medicine</topic><topic>Thrombin - analysis</topic><topic>Trails</topic><topic>Ultramarathon</topic><topic>Women</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kupchak, Brian R.</creatorcontrib><creatorcontrib>Volk, Brittanie M.</creatorcontrib><creatorcontrib>Kunces, Laura J.</creatorcontrib><creatorcontrib>Kraemer, William J.</creatorcontrib><creatorcontrib>Hoffman, Martin D.</creatorcontrib><creatorcontrib>Phinney, Stephen D.</creatorcontrib><creatorcontrib>Volek, Jeff S.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database (ProQuest)</collection><collection>ProQuest_Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest Biological Science Journals</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>Physical Education Index</collection><jtitle>European journal of applied physiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kupchak, Brian R.</au><au>Volk, Brittanie M.</au><au>Kunces, Laura J.</au><au>Kraemer, William J.</au><au>Hoffman, Martin D.</au><au>Phinney, Stephen D.</au><au>Volek, Jeff S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Alterations in coagulatory and fibrinolytic systems following an ultra-marathon</atitle><jtitle>European journal of applied physiology</jtitle><stitle>Eur J Appl Physiol</stitle><addtitle>Eur J Appl Physiol</addtitle><date>2013-11-01</date><risdate>2013</risdate><volume>113</volume><issue>11</issue><spage>2705</spage><epage>2712</epage><pages>2705-2712</pages><issn>1439-6319</issn><eissn>1439-6327</eissn><abstract>Purpose
The aim of this study was to examine coagulatory and fibrinolytic responses to the Western States Endurance Run (WSER, June 23 to 24, 2012). The WSER is a 161-km (100 mile) trail foot race through the Sierra Nevada Mountains that involves 6,030 m of climb and 7,001 m of descent.
Methods
We examined 12 men and 4 women [mean (95 % CI), age 44.6 years (38.7–50.6)] who completed the race (24.64 h; range 16.89–29.46). Blood samples were collected the morning before the race, immediately post-race, and 1 (D1) and 2 (D2) days post-race (corresponding to 51–54 h and 75–78 h from the start of the race, respectively). Hypercoagulable state was characterized by prothrombin fragment 1+2 (PTF 1+2) and thrombin–antithrombin complex (TAT). Fibrinolytic state was assessed by plasminogen activator inhibitor antigen (PAI-1 Ag), tissue plasminogen activator antigen (tPA Ag), and
d
-Dimer. Muscle damage was assessed by serum creatine kinase (CK) and myoglobin concentrations.
Results
Significant (
P
≤ 0.05) increases were observed immediately post-race for thrombin generation markers, PTF 1+2 (3.9-fold) and TAT (2.4-fold); markers of fibrinolysis, tPA Ag (4.0-fold), PAI-1 Ag (4.5-fold), and
d
-Dimer (2.2-fold); and muscle damage markers, CK (154-fold) and myoglobin (114-fold). Most markers continued to be elevated at D1, as seen by PTF 1+2, TAT (1.5- and 1.3-fold increase at D1), and
d
-Dimer (2.5- and 2.1-fold increase at D1 and D2, respectively). Additionally, PTF 1+2:tPA and TAT:tPA ratios, which assessed balance between coagulation and fibrinolysis, were slightly, but significantly increased at D1 (69 and 36 %) and D2 (19 and 31 %). CK and myoglobin also remained elevated at D1 (54- and 7-fold) and D2 (25- and 2-fold) time points.
Conclusion
The WSER produced extensive muscle damage and activated the coagulation and fibrinolytic systems. Since we observed a slight imbalance response between the two systems, a limited potential for thrombotic episodes is apparent in these highly trained athletes.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>23974848</pmid><doi>10.1007/s00421-013-2709-5</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1439-6319 |
ispartof | European journal of applied physiology, 2013-11, Vol.113 (11), p.2705-2712 |
issn | 1439-6319 1439-6327 |
language | eng |
recordid | cdi_proquest_miscellaneous_1622605978 |
source | Springer Nature |
subjects | Adult Altitude Antigens Biomedical and Life Sciences Biomedicine Creatine Kinase - blood Female Fibrinolysis Human Physiology Humans Male Marathons Middle Aged Myoglobin - blood Occupational Medicine/Industrial Medicine Original Article Physical Endurance - physiology Plasminogen Inactivators - blood Prothrombin - analysis Running - physiology Sports Medicine Thrombin - analysis Trails Ultramarathon Women |
title | Alterations in coagulatory and fibrinolytic systems following an ultra-marathon |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T04%3A33%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Alterations%20in%20coagulatory%20and%20fibrinolytic%20systems%20following%20an%20ultra-marathon&rft.jtitle=European%20journal%20of%20applied%20physiology&rft.au=Kupchak,%20Brian%20R.&rft.date=2013-11-01&rft.volume=113&rft.issue=11&rft.spage=2705&rft.epage=2712&rft.pages=2705-2712&rft.issn=1439-6319&rft.eissn=1439-6327&rft_id=info:doi/10.1007/s00421-013-2709-5&rft_dat=%3Cproquest_cross%3E1622605978%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c405t-8f736164a0db8574c7598786e7a8e5d0802df4ecfa2af813d7da405d30d2a37c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1563697905&rft_id=info:pmid/23974848&rfr_iscdi=true |